A significant reduction in H3K36 methylation was also found in both ccRCC cell lines and patient samples, suggesting the potential involvement of SETD2 in driving ccRCC metastatic progression (8, 9). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.